- Exchange: GreTai Sec M
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for PharmaEngine Inc (4162)
| Open: | 177.00 | Day's Range: | 171.00 - 179.00 | Volume: | 677,816 |
|---|---|---|---|---|---|
| Previous Close: | 176.50 | 52wk Range: | 92.00 - 225.50 | 1-Yr Rtn: | +41.97% |
Key Statistics for 4162
| Current P/E Ratio (ttm) | 295.6897 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. TWOTCI | 9.9661 |
| Earnings Per Share (ttm) | 0.5800 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M TWD) | 15,792.58 |
| Shares Outstanding (M) | 92.09 |
| 30 Day Average Volume | 971,050 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/15/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4162
No data available
Company Profile & Key Executives for 4162
PharmaEngine, Inc. operates as a biopharmaceutical company. The Company focuses on the development of new drugs for the treatment of cancer and Asian prevalent diseases.
| Lin Jung-ChinChairman | Grace C YehPresident/CEO |
| Hsieh Tiao-LinSenior Manager | Alain HerreraSenior Advisor |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4162 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page